PAMCX
Price
$95.07
Change
+$1.09 (+1.16%)
Updated
Dec 20 closing price
RYCKX
Price
$36.10
Change
+$0.11 (+0.31%)
Updated
Dec 20 closing price
Ad is loading...

PAMCX vs RYCKX

Header iconPAMCX vs RYCKX Comparison
Open Charts PAMCX vs RYCKXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$95.07
Change+$1.09 (+1.16%)
VolumeN/A
CapitalizationN/A
Rydex S&P MidCap 400 Pure Growth C
Price$36.10
Change+$0.11 (+0.31%)
VolumeN/A
CapitalizationN/A
PAMCX vs RYCKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAMCX vs. RYCKX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and RYCKX is a Hold.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 30.3B vs. RYCKX (31.4M). PAMCX (0.00) and RYCKX (0.00) have matching dividends . PAMCX was incepted earlier than RYCKX: PAMCX (25 years) vs RYCKX (21 years). RYCKX is a more actively managed with annual turnover of: 372.00 vs. PAMCX (21.70). PAMCX (2500) and RYCKX (2500) have matching initial minimum investment requirements. PAMCX annual gain was more profitable for investors over the last year : 1.02 vs. RYCKX (-3.32). PAMCX return over 5 years is better than : 3.26 vs. RYCKX (-6.72).
PAMCXRYCKXPAMCX / RYCKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years21 years-
Gain YTD0.063-2.983-2%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets30.3B31.4M96,497%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.02-3.32-31%
Returns for 3 years-13.30-23.3557%
Returns for 5 years3.26-6.72-48%
Returns for 10 years28.18-19.69-143%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGYS138.673.81
+2.83%
Agilysys
ACNT11.300.30
+2.73%
Ascent Industries Co
WPP52.29-0.29
-0.55%
WPP PLC
EHAB7.65-0.05
-0.65%
Enhabit
ATXI1.77-0.03
-1.67%
Avenue Therapeutics